Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dunlop

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Bone & Joint Open|May 18, 2021
Morbidity and mortality in patients undergoing lower limb arthroplasty surgery during the initial surge of the COVID-19 pandemic in the UK at a single-speciality orthopaedic hospitalYuvraj Agrawal, Ashish Vasudev, Akash Sharma, et al.
The Journal of Arthroplasty|October 16, 2004
Patient satisfaction and functional status after aseptic versus septic revision total knee arthroplasty using the PROSTALAC articulating spacerR M Dominic Meek, David Dunlop, Donald S Garbuz, et al.
The Journal of Bone and Joint Surgery. American Volume|October 18, 2003
Patient satisfaction and functional status after treatment of infection at the site of a total knee arthroplasty with use of the PROSTALAC articulating spacerR M Dominic Meek, Bassam A Masri, David Dunlop, et al.
Inorganic Chemistry|May 4, 2021
Luminescent Cationic Group 4 Metallocene Complexes Stabilized by Pendant N-Donor GroupsDavid Dunlop, Miloš Večeřa, Róbert Gyepes, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2011
A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)Heather A Wakelee, Gary Middleton, David Dunlop, et al.
Cost Effectiveness and Resource Allocation : C/E|August 31, 2012
Budgeting based on need: a model to determine sub-national allocation of resources for health services in IndonesiaTim Ensor, Hafidz Firdaus, David Dunlop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2009
Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokersAndrew N Hughes, Mary E R O'Brien, W Jeffrey Petty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Phase II study of imatinib in patients with small cell lung cancerBruce E Johnson, Thomas Fischer, Berthold Fischer, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2011
The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancerHeather A Wakelee, Chris H Takimoto, Arturo Lopez-Anaya, et al.
Macromolecular Bioscience|September 21, 2020
Chelating Polymers for Hereditary Hemochromatosis TreatmentOndřej Groborz, Lenka Poláková, Kristýna Kolouchová, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Bone & Joint Open|May 18, 2021
Morbidity and mortality in patients undergoing lower limb arthroplasty surgery during the initial surge of the COVID-19 pandemic in the UK at a single-speciality orthopaedic hospitalYuvraj Agrawal, Ashish Vasudev, Akash Sharma, et al.
The Journal of Arthroplasty|October 16, 2004
Patient satisfaction and functional status after aseptic versus septic revision total knee arthroplasty using the PROSTALAC articulating spacerR M Dominic Meek, David Dunlop, Donald S Garbuz, et al.
The Journal of Bone and Joint Surgery. American Volume|October 18, 2003
Patient satisfaction and functional status after treatment of infection at the site of a total knee arthroplasty with use of the PROSTALAC articulating spacerR M Dominic Meek, Bassam A Masri, David Dunlop, et al.
Inorganic Chemistry|May 4, 2021
Luminescent Cationic Group 4 Metallocene Complexes Stabilized by Pendant N-Donor GroupsDavid Dunlop, Miloš Večeřa, Róbert Gyepes, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2011
A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)Heather A Wakelee, Gary Middleton, David Dunlop, et al.
Cost Effectiveness and Resource Allocation : C/E|August 31, 2012
Budgeting based on need: a model to determine sub-national allocation of resources for health services in IndonesiaTim Ensor, Hafidz Firdaus, David Dunlop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2009
Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokersAndrew N Hughes, Mary E R O'Brien, W Jeffrey Petty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Phase II study of imatinib in patients with small cell lung cancerBruce E Johnson, Thomas Fischer, Berthold Fischer, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2011
The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancerHeather A Wakelee, Chris H Takimoto, Arturo Lopez-Anaya, et al.
Macromolecular Bioscience|September 21, 2020
Chelating Polymers for Hereditary Hemochromatosis TreatmentOndřej Groborz, Lenka Poláková, Kristýna Kolouchová, et al.
Pageof 3